Journal article · 2026 · Open access
Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review
International Journal of Therapeutic Innovation., 4(2), 12–15 · Published 28 April 2026 · DOI 10.55522/ijti.v4i2.0143
In brief
“Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review” is a 2026 journal article by Nikita Mahadev Ghadage, published in International Journal of Therapeutic Innovation.. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Therapeutic Innovation..
- Citations
- 0
- Authors
- 1
Abstract
Poor aqueous solubility continues to be a critical barrier in the development of effective oral drug delivery systems, particularly for compounds classified under BCS Class II and IV. Although these molecules possess strong therapeutic promise, their clinical performance is often compromised by inadequate dissolution, restricted gastrointestinal absorption, and extensive first-pass metabolism. Solid lipid nanoparticles (SLNs) have gained considerable attention as an advanced nanocarrier platform capable of overcoming these limitations by improving drug solubilization, stabilizing chemically sensitive molecules, enhancing membrane permeability, and enabling controlled or site-specific release. This review provides a comprehensive overview of the fundamental concepts underlying SLN technology, including formulation principles, key preparation methods, and current characterization techniques. In addition, recent therapeutic applications of SLNs for enhancing the bioavailability of poorly soluble drugs are critically examined. The discussion also addresses existing challenges such as stability issues, drug expulsion, and scale-up complexities, along with potential safety considerations. Emerging innovations—such as targeted SLN systems, hybrid lipid matrices, and the integration of artificial intelligence in formulation design—are highlighted as promising directions for future development. Overall, SLNs represent a biocompatible and versatile nanotechnology platform with substantial potential to improve the clinical translation of poorly water-soluble therapeutic agents.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ghadage, N. M. (2026). Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review. International Journal of Therapeutic Innovation., 4(2), 12–15. https://doi.org/10.55522/ijti.v4i2.0143
MLA 9
Ghadage, Nikita Mahadev. “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review.” International Journal of Therapeutic Innovation., vol. 4, no. 2, 2026, pp. 12–15. https://doi.org/10.55522/ijti.v4i2.0143.
Chicago
Ghadage, Nikita Mahadev. 2026. “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review.” International Journal of Therapeutic Innovation. 4 (2): 12–15. https://doi.org/10.55522/ijti.v4i2.0143.
Harvard
Ghadage, N. M. (2026) ‘Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review’, International Journal of Therapeutic Innovation., 4(2), pp. 12–15. doi:10.55522/ijti.v4i2.0143.
IEEE
N. M. Ghadage, “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review,” International Journal of Therapeutic Innovation., vol. 4, no. 2, pp. 12–15, 2026, doi: 10.55522/ijti.v4i2.0143.
BibTeX
@article{ghadage2026solid,
title = {{Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review}},
author = {Ghadage, Nikita Mahadev},
journal = {International Journal of Therapeutic Innovation.},
year = {2026},
volume = {4},
number = {2},
pages = {12--15},
doi = {10.55522/ijti.v4i2.0143},
url = {https://doi.org/10.55522/ijti.v4i2.0143}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- solid lipid nanoparticles
- bioavailability enhancement
- poorly water-soluble drugs
- oral drug delivery
- BCS Class II and IV drugs
- nanocarriers
- drug solubilization
- gastrointestinal absorption
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Ghadage, N. M. (2026). Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review. International Journal of Therapeutic Innovation., 4(2), 12–15. https://doi.org/10.55522/ijti.v4i2.0143
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at International Journal of Therapeutic Innovation..
Who wrote this paper?
Nikita Mahadev Ghadage.
What is the DOI of this paper?
10.55522/ijti.v4i2.0143. The permanent link is https://doi.org/10.55522/ijti.v4i2.0143.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.